Stay updated on High CRC/Pancreatic Clinical Trial
Sign up to get notified when there's something new on the High CRC/Pancreatic Clinical Trial page.

Latest updates to the High CRC/Pancreatic Clinical Trial page
- Check6 days agoChange DetectedJulie Koenig, MD is now listed as the responsible party at Massachusetts General Hospital (Boston, MA 02114), replacing Theodore Hong, MD. The update also includes a new last update date and Revision: v3.3.4.SummaryDifference0.8%

- Check13 days agoNo Change Detected
- Check20 days agoNo Change Detected
- Check27 days agoChange DetectedAdded a dedicated Locations section with Massachusetts listed as a study site. The footer was updated to Revision v3.3.3, and the standalone Massachusetts Locations entry and the HHS Vulnerability Disclosure link were removed.SummaryDifference0.2%

- Check56 days agoChange DetectedEditorial wording in the Publications section was updated to clarify that publications are automatically filled from PubMed. The revision label was updated from v3.2.0 to v3.3.2.SummaryDifference0.1%

- Check63 days agoChange DetectedThe government funding lapse notice at the top of the page was removed. The study details themselves appear unchanged.SummaryDifference0.4%

- Check77 days agoChange DetectedCore study details such as eligibility criteria, outcomes, and locations remain substantively unchanged. The updates appear limited to metadata and formatting without affecting the protocol or study status.SummaryDifference0.5%

- Check106 days agoChange DetectedAdded a government operating status notice and a v3.2.0 revision; removed the previous v3.1.0 revision. The page now communicates potential service delays and open NIH Clinical Center status, plus the updated software version.SummaryDifference3%

Stay in the know with updates to High CRC/Pancreatic Clinical Trial
Enter your email address, and we'll notify you when there's something new on the High CRC/Pancreatic Clinical Trial page.